TD-1

• UNSPSC Description:

  TD-1 (Transdermal peptide) is a short peptide that can promote the delivery of macromolecule drugs, especially protein drugs, through the skin barrier. TD-1 can significantly improve the transdermal delivery efficiency of protein drugs such as insulin and human growth hormone, allowing them to reach systemic circulation. Research on TD-1 transdermal drug delivery system[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/td-1.html

• Smiles:

  O=C(O)CNC([C@H](CS)NC([C@H](CC1=CNC=N1)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H]2N(C([C@H](CO)NC([C@H](CO)NC([C@H](CO)NC([C@H](CS)NC([C@H](C)N)=O)=O)=O)=O)=O)CCC2)=O)=O)=O)=O)=O

• Molecular Weight:

  1063.17

• References & Citations:

  [1]Chen Y, et al. Transdermal protein delivery by a coadministered peptide identified via phage display[J]. Nature biotechnology, 2006, 24(4): 455-460.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  918629-48-8